George W. Lloyd - 06 Aug 2025 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Aug 2025, 16:56:59 UTC
Prior SEC filing
20 May 2025
Next SEC filing
07 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd

Key filing fact

George W. Lloyd filed Form 4 for Royalty Pharma plc (RPRX) on 08 Aug 2025.

Key facts

  • This page summarizes George W. Lloyd's Form 4 filing for Royalty Pharma plc (RPRX).
  • 2 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 08 Aug 2025, 16:56.

Change

  • Previous filing in this sequence was filed on 20 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001814899 Primary reporting owner

Lloyd George W.

Relationship
EVP, Investments & CLO
Address
C/O ROYALTY PHARMA PLC, 110 EAST 59TH STREET, NEW YORK
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
Signature date
08 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RPRX transaction

Class A Ordinary Shares

Award

Transaction value
$0
Shares
+3,696
Change %
+7.6%
Price
$0.000000
Shares after
52,342
Date
06 Aug 2025
Ownership
By GWL 2023 G HoldCo LLC
Footnotes
F1
RPRX holding

Class A Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,000
Date
06 Aug 2025
Ownership
Direct
RPRX holding

Class A Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
273,960
Date
06 Aug 2025
Ownership
By IRA
RPRX holding

Class A Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
495,860
Date
06 Aug 2025
Ownership
By GWL 2013 NG, LLC
RPRX holding

Class A Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
220,000
Date
06 Aug 2025
Ownership
By GWL 2014 G, LLC
RPRX holding

Class A Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
52,000
Date
06 Aug 2025
Ownership
By GWL 2020 G, LLC
RPRX holding

Class A Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
28,000
Date
06 Aug 2025
Ownership
By GWL 2021 G, LLC
RPRX holding

Class A Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,011
Date
06 Aug 2025
Ownership
By Spouse

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RPRX transaction Derivative

LP interests in RPI US Partners 2019, LP

Gift

Transaction value
$0
Shares
-8,500
Change %
-100%
Price
$0.000000
Shares after
0
Date
08 Aug 2025
Ownership
Direct
Underlying class
Class A Ordinary Shares
Underlying amount
85,000
Exercise price
Footnotes
F2, F3
RPRX holding Derivative

LP interests in RPI US Partners 2019, LP

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
58,173
Date
06 Aug 2025
Ownership
By GWL 2013 NG, LLC
Underlying class
Class A Ordinary Shares
Underlying amount
581,730
Exercise price
$0.000000
Footnotes
F3
RPRX holding Derivative

LP interests in RPI US Partners 2019, LP

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
291,739
Date
06 Aug 2025
Ownership
By GWL 2014 G, LLC
Underlying class
Class A Ordinary Shares
Underlying amount
2,917,390
Exercise price
$0.000000
Footnotes
F3
RPRX holding Derivative

LP interests in RPI US Partners 2019, LP

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
272,672
Date
06 Aug 2025
Ownership
By GWL 2020 G, LLC
Underlying class
Class A Ordinary Shares
Underlying amount
2,726,720
Exercise price
$0.000000
Footnotes
F3
RPRX holding Derivative

LP interests in RPI US Partners 2019, LP

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
130,148
Date
06 Aug 2025
Ownership
By GWL 2021 G LLC
Underlying class
Class A Ordinary Shares
Underlying amount
1,301,480
Exercise price
$0.000000
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.

Footnote F2

No limited partnership interests in RPI US Partners 2019, LP ("RPI US LP") are being exchanged by the Reporting Person. Each limited partnership interest in RPI US LP ("RPI US LP Interest") may be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. Any exchanges will be made pursuant to the terms of the Amended and Restated Exchange Agreement. No additional value will be paid by the Reporting Person in connection with an exchange.

Footnote F3

Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .